QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

21,066 signal articles · 543 in last 24h · 103,602 total before filter · latest 9m ago
543last 24h
2521last 7d
483● bullish (7d)
259● bearish (7d)
197publishers
AllMacro247Earnings1481M&A141Regulatory16Product4Analyst30
✕ clear all filtersticker: HIMSSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
BofA Cuts Hims & Hers Price Target as Mixed Quarter Resets Street Expectations
24/7 Wall St.84d agobearish
BofA Cuts Hims & Hers Price Target as Mixed Quarter Resets Street Expectations

Hims & Hers Health (NYSE:HIMS) absorbed another analyst downgrade. Bank of America cut its price objective on Hims & Hers stock to $30 from $32, while keeping a Neutral rating. The firm called the recent results “a mixed quarter” and argued that the bar needs to come down before HIMS stock can work again. The ... BofA Cuts Hims & Hers Price Target as Mixed Quarter Resets Street Expectations

JPMorgan Cuts Hims & Hers Price Target as GLP-1 Shift Reshapes the Growth Story
24/7 Wall St.85d agobearish
JPMorgan Cuts Hims & Hers Price Target as GLP-1 Shift Reshapes the Growth Story

Shares of Hims & Hers Health (NYSE:HIMS) are under pressure after JPMorgan trimmed its price target on the consumer telehealth name following a messy first quarter. The firm lowered its price target to $33 from $35 while reaffirming an Overweight rating, characterizing results as mixed and updating the 2026 outlook to reflect the strategic shift ... JPMorgan Cuts Hims & Hers Price Target as GLP-1 Shift Reshapes the Growth Story